From November 3, 2023 to December 7, 2023, the company has repurchased 1,550,900 shares, representing 0.38% for CNY 29.99 million. With this, the company has completed the repurchase of 1,550,900 shares, representing 0.38% for CNY 29.99 million under the buyback announced on November 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.72 CNY | -3.49% |
|
-3.56% | -32.63% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.63% | 714M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+13.98% | 240B | |
+14.40% | 221B | |
-0.20% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 4, 2023.